Stocks in Focus: Finisar Corporation (NASDAQ:FNSR), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Hospira, Inc.(NYSE:HSP)

Dallas, TX -- (SBWIRE) -- 03/15/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Finisar Corporation (NASDAQ:FNSR) shares jumped 5.60% to $14.71. 3S PHOTONICS and Finisar Corporation on Mar. 12 announced their formal agreement to launch a partnership for the development of a new packaging platform for 980nm cooled laser pump modules.

Additionally, the company, on Mar. 7, reported a higher quarterly profit, helped by an increase in demand for its fiber optic products. Net profit grew to $16.3 million, or 17 cents per share, in the third quarter from $14.2 million, or 15 cents per share, a year earlier. Revenue for the third-quarter rose 2.7 percent to $238.4 million.

Get Latest News, Updates on FNSR Here

ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) shares climbed 3.33% and closed at $5.43. The company, on Mar. 11, announced the initiation of a randomized, open label Phase 2 clinical study of Ad-RTS IL-12 in combination with palifosfamide to treat patients with non-resectable recurrent or metastatic breast cancer. The two-part, multi-center U.S. study will enroll up to 68 patients with non-resectable, recurrent or metastatic breast cancer who have visible lesions or lesions accessible by injection.

Is ZIOP a Strong Buying Opportunity After The Recent Slump? Find out Here

Hospira, Inc.(NYSE:HSP) shares gained 3.22% and closed at $31.74. The company, on Mar. 1, announced that Royce R. Bedward has been appointed corporate vice president, general counsel and secretary, effective immediately. In his new role, Mr. Bedward will oversee the company's legal department, including litigation, benefits, labor and employment, intellectual property, governance, securities and transactional matters.

Additonally, HSP released reports that U.S. health regulators issued a letter raising new concerns about one of the injectable-drugs maker's largest manufacturing plants in Rocky Mount, N.C. This sent the company's shares down by four percent, according to The Chicago Tribune on Mar. 5.

Is HSP Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here

About Marketbuzzreport.com
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com

Disclaimer
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.